PTEN and melanoma: Consistently, pharmacological targeting of PTEN after immunotherapy with vaccine/T cells or chemotherapy in melanoma mouse models profoundly reprogrammed the tumor microenvironment from a suppressive to a proinflammatory milieu, with rapid regression of tumors.